Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Regulation of antiviral and antitumor immunity by the BRCA1 pseudogene in human cancers.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 04, 2026
Triple negative breast cancer: what clinical progress have we seen in the last 5 years?
Journal: Expert opinion on investigational drugs
Published: February 07, 2026
What is Optimal Neoadjuvant Therapy in HER2-Positive Breast Cancer?
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 05, 2026
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial.
Journal: JAMA network open
Published: February 03, 2026
Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores-Reply.
Journal: JAMA oncology
Published: July 27, 2023
DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development.
Journal: NPJ breast cancer
Published: February 27, 2020
Estrogen-mediated protection against coronary heart disease: The role of the Notch pathway.
Journal: The Journal of steroid biochemistry and molecular biology
Published: December 04, 2018
Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination.
Journal: Journal of berry research
Published: July 07, 2018
Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 25, 2017
Last Updated: 09/26/2026